MENU
+Compare
FENC
Stock ticker: NASDAQ
AS OF
Jun 27 closing price
Price
$8.25
Change
-$0.03 (-0.36%)
Capitalization
227.38M

FENC Fennec Pharmaceuticals Forecast, Technical & Fundamental Analysis

Fennec Pharmaceuticals Inc is a commercial-stage biopharmaceutical company... Show more

Industry: #Biotechnology
FENC
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
Interact to see
Advertisement
A.I.Advisor
a Summary for FENC with price predictions
Jun 27, 2025

FENC sees MACD Histogram just turned negative

FENC saw its Moving Average Convergence Divergence Histogram (MACD) turn negative on June 04, 2025. This is a bearish signal that suggests the stock could decline going forward. Tickeron's A.I.dvisor looked at 45 instances where the indicator turned negative. In of the 45 cases the stock moved lower in the days that followed. This puts the odds of a downward move at .

Price Prediction Chart

Technical Analysis (Indicators)

Bearish Trend Analysis

The 10-day RSI Indicator for FENC moved out of overbought territory on June 09, 2025. This could be a bearish sign for the stock. Traders may want to consider selling the stock or buying put options. Tickeron's A.I.dvisor looked at 31 similar instances where the indicator moved out of overbought territory. In of the 31 cases, the stock moved lower in the following days. This puts the odds of a move lower at .

The Stochastic Oscillator may be shifting from an upward trend to a downward trend. In of 67 cases where FENC's Stochastic Oscillator exited the overbought zone, the price fell further within the following month. The odds of a continued downward trend are .

The Momentum Indicator moved below the 0 level on June 27, 2025. You may want to consider selling the stock, shorting the stock, or exploring put options on FENC as a result. In of 112 cases where the Momentum Indicator fell below 0, the stock fell further within the subsequent month. The odds of a continued downward trend are .

Following a 3-day decline, the stock is projected to fall further. Considering past instances where FENC declined for three days, the price rose further in of 62 cases within the following month. The odds of a continued downward trend are .

Bullish Trend Analysis

The Aroon Indicator entered an Uptrend today. In of 194 cases where FENC Aroon's Indicator entered an Uptrend, the price rose further within the following month. The odds of a continued Uptrend are .

Fundamental Analysis (Ratings)

The Tickeron Price Growth Rating for this company is (best 1 - 100 worst), indicating steady price growth. FENC’s price grows at a higher rate over the last 12 months as compared to S&P 500 index constituents.

The Tickeron Profit vs. Risk Rating rating for this company is (best 1 - 100 worst), indicating that the returns do not compensate for the risks. FENC’s unstable profits reported over time resulted in significant Drawdowns within these last five years. A stable profit reduces stock drawdown and volatility. The average Profit vs. Risk Rating rating for the industry is 95, placing this stock better than average.

The Tickeron Valuation Rating of (best 1 - 100 worst) indicates that the company is significantly overvalued in the industry. This rating compares market capitalization estimated by our proprietary formula with the current market capitalization. This rating is based on the following metrics, as compared to industry averages: P/B Ratio (52.910) is normal, around the industry mean (16.366). P/E Ratio (60.429) is within average values for comparable stocks, (58.189). FENC's Projected Growth (PEG Ratio) (0.000) is slightly lower than the industry average of (2.309). Dividend Yield (0.000) settles around the average of (0.041) among similar stocks. P/S Ratio (7.321) is also within normal values, averaging (252.247).

The Tickeron PE Growth Rating for this company is (best 1 - 100 worst), pointing to worse than average earnings growth. The PE Growth rating is based on a comparative analysis of stock PE ratio increase over the last 12 months compared against S&P 500 index constituents.

The Tickeron SMR rating for this company is (best 1 - 100 worst), indicating weak sales and an unprofitable business model. SMR (Sales, Margin, Return on Equity) rating is based on comparative analysis of weighted Sales, Income Margin and Return on Equity values compared against S&P 500 index constituents. The weighted SMR value is a proprietary formula developed by Tickeron and represents an overall profitability measure for a stock.

View a ticker or compare two or three
FENC
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
Interact to see
Advertisement
A.I. Advisor
published Earnings

FENC is expected to report earnings to rise 5.00% to -4 cents per share on August 07

Fennec Pharmaceuticals FENC Stock Earnings Reports
Q2'25
Est.
$-0.04
Q1'25
Beat
by $0.06
Q4'24
Beat
by $0.07
Q3'24
Missed
by $0.11
Q2'24
Missed
by $0.18
The last earnings report on May 13 showed earnings per share of -3 cents, beating the estimate of -10 cents. With 196.82K shares outstanding, the current market capitalization sits at 227.38M.
A.I. Advisor
published General Information

General Information

a developer of therapeutic products based on cell adhesion

Industry Biotechnology

Profile
Fundamentals
Details
Industry
Biotechnology
Address
68 TW Alexander Drive
Phone
+1 919 636-4530
Employees
29
Web
https://www.fennecpharma.com
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
STOCK / NAMEPrice $Chg $Chg %
PGZFF0.110.01
+6.92%
Pan Global Resource, Inc.
WHTCF2.880.04
+1.33%
Well Health Technologies Corp.
ATMH0.08N/A
N/A
ALL THINGS MOBILE ANALYTIC INC.
CHBAF8.01N/A
N/A
Chiba Bank, Ltd. (The)
OEZVY16.15N/A
N/A
Verbund AG

FENC and Stocks

Correlation & Price change

A.I.dvisor indicates that over the last year, FENC has been loosely correlated with DNLI. These tickers have moved in lockstep 48% of the time. This A.I.-generated data suggests there is some statistical probability that if FENC jumps, then DNLI could also see price increases.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To FENC
1D Price
Change %
FENC100%
-0.36%
DNLI - FENC
48%
Loosely correlated
-2.69%
CLDX - FENC
45%
Loosely correlated
-4.16%
IDYA - FENC
44%
Loosely correlated
-4.13%
BEAM - FENC
44%
Loosely correlated
-1.98%
ATXS - FENC
43%
Loosely correlated
N/A
More